Charles River Laboratories Hits New 52-Week High at $241.93

Charles River Laboratories International, Inc. has reached a significant milestone by hitting a new 52-week high of USD 241.93 on July 28, 2026. This achievement highlights the company's strong performance within the miscellaneous industry, where it operates as a small-cap entity with a market capitalization of USD 7,858 million. Over the past year, Charles River Laboratories has demonstrated a performance increase of 12.08%, although it trails behind the S&P 500's performance of 16.26%. The company's price-to-earnings (P/E) ratio stands at 26.00, indicating its valuation relative to earnings. Additionally, the firm maintains a debt-to-equity ratio of 0.62, reflecting a balanced approach to leveraging. With a return on equity of 9.58% and a price-to-book ratio of 2.48, Charles River Laboratories continues to showcase its financial health and operational efficiency. The stock's previous 52-week low was recorded at USD 144.26, marking a notable recovery and upward trend in its market performance.